Elan posts encouraging results
Elan today reported its first-quarter 2009 financial results.
The pharmacuetical firm announced a 14% increase in revenue to $245.1m (€189.3m) and Adjusted EBITDA losses reduced by 59% to $6m (€4.6m), compared to the first quarter of 2008.
The Business Hub
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.





